InfuSystems Holdings Inc (INFU)
6.44
+0.10
(+1.58%)
USD |
NYAM |
May 17, 16:00
6.47
+0.03
(+0.47%)
After-Hours: 20:00
InfuSystems Holdings SG&A Expense (Quarterly): 17.07M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 17.07M |
December 31, 2023 | 13.26M |
September 30, 2023 | 14.47M |
June 30, 2023 | 15.01M |
March 31, 2023 | 14.81M |
December 31, 2022 | 12.59M |
September 30, 2022 | 14.66M |
June 30, 2022 | 14.02M |
March 31, 2022 | 15.14M |
December 31, 2021 | 10.95M |
September 30, 2021 | 14.47M |
June 30, 2021 | 13.30M |
March 31, 2021 | 12.73M |
December 31, 2020 | 12.64M |
September 30, 2020 | 10.78M |
June 30, 2020 | 10.16M |
March 31, 2020 | 11.27M |
December 31, 2019 | 10.49M |
September 30, 2019 | 9.338M |
June 30, 2019 | 9.352M |
March 31, 2019 | 9.734M |
December 31, 2018 | 7.94M |
September 30, 2018 | 8.609M |
June 30, 2018 | 8.725M |
March 31, 2018 | 8.462M |
Date | Value |
---|---|
December 31, 2017 | 7.922M |
September 30, 2017 | 7.823M |
June 30, 2017 | 8.72M |
March 31, 2017 | 9.351M |
December 31, 2016 | 8.329M |
September 30, 2016 | 7.757M |
June 30, 2016 | 8.716M |
March 31, 2016 | 9.484M |
December 31, 2015 | 8.471M |
September 30, 2015 | 8.338M |
June 30, 2015 | 8.681M |
March 31, 2015 | 8.712M |
December 31, 2014 | 7.248M |
September 30, 2014 | 7.399M |
June 30, 2014 | 7.522M |
March 31, 2014 | 7.564M |
December 31, 2013 | 6.728M |
September 30, 2013 | 6.974M |
June 30, 2013 | 7.49M |
March 31, 2013 | 7.439M |
December 31, 2012 | 7.603M |
September 30, 2012 | 7.627M |
June 30, 2012 | 8.678M |
March 31, 2012 | 9.018M |
December 31, 2011 | 7.042M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
9.338M
Minimum
Sep 2019
17.07M
Maximum
Mar 2024
12.83M
Average
13.00M
Median
SG&A Expense (Quarterly) Benchmarks
Haemonetics Corp | 121.68M |
Perspective Therapeutics Inc | 5.878M |
Xtant Medical Holdings Inc | 20.24M |
Asensus Surgical Inc | 8.016M |
Catheter Precision Inc | 2.656M |